Topoisomerases and cancer treatment.
Baguley
B C
BC
University of Auckland School of Medicine.
D000970:Antineoplastic Agents / Q000494:pharmacology*; D004250:DNA Topoisomerases, Type II / Q000187:drug effects* / Q000235:genetics; D004351:Drug Resistance; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents; D004250:DNA Topoisomerases, Type II